{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig6eyxu5f7zebn5zowworz4r73jxkcilbu3spqrk6msqyl5h27qla",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mikzqxbrw2x2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiezv3c3mg2nfyrxlcfyojhq3dfpr74is3iyyb6hddmjwtzwndz5vi"
    },
    "mimeType": "image/jpeg",
    "size": 64211
  },
  "path": "/2026/04/02/biotech-news-foundayo-is-here-o-novo-responds/?utm_campaign=rss",
  "publishedAt": "2026-04-02T13:47:33.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Potential import tariffs on drugs, Foundayo is here-o, and other biotech news from The Readout",
  "title": "STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds",
  "updatedAt": "2026-04-02T13:47:38.000Z"
}